Claratin news from FierceBiotech
Press Releases
PRESS RELEASE: Schering-Plough/Merck Announce FDA Filing Acceptance of NDA for Loratadine/Montelukast Tablet
Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet KENILWORTH and WHITEHOUSE STATION, N.J., Aug. 28 -- Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets